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for symptomatic relief of pancytopenia. At 
that time, patent foramen ovale and a slightly 
enlarged left ventricle were detected and left 
untreated. At 6 years of age the patient had 
been admitted to the hospital with a closed 
fracture in the upper third of the left femur, 
and anemia (Hb 8.9 g/dl) was still present. 
From the age of 7 years the patient had com-
plained of recurrent bone pain especially in 
the spine. At 11 years of age compression 
fractures of the T3, T4, T5 and T6 vertebrae 
had been found. A provisional diagnosis of 
Kummell disease had been made and the 
patient had undergone non-operative treat-
ment to stabilize the vertebral column.
Physical examination revealed a criti-
cal condition with grade 4 dyspnea, low 
oxygen saturation (89% on O2 through 
face mask), pallor, abdominal distension, 
and massively enlarged liver extending into 
the pelvis. Blood tests showed Hb 7.7 g/dl, 
WBC 6.51 × 109/L, platelets 206 × 109/L, 
a 17 year old girl was referred to the National Research Center for Maternal 
and Child Health of the Nazarbayev Univer- 
sity Medical Center in Astana, Kazakhstan 
in June 2016 with a 4 month history of easy 
fatigability, dyspnea, abdominal distension, 
and episodic fainting. 
The family history showed only an 
unspecified hematological disease as the 
cause of death of her grandmother. The 
patient had been anemic since the age of 2 
years, and was then found to have massive 
splenomegaly with pancytopenia. She had 
been splenectomised at the age of 4 years 
prothrombin time 18 sec, AST 71 IU/L 
(normal < 59), and ALT 41 IU/L (normal < 29). 
A chest X-ray [Figure 1] showed car-
diomegaly, dilated pulmonary artery and 
elevation of the right diaphragmatic dome 
secondary to massive hepatomegaly. An 
ECG demonstrated sinus tachycardia (106 
bpm) and right axis deviation. An echocar-
diogram revealed 58% ejection fraction, 
atrial septal defect with pronounced right 
atrium, right ventricle and pulmonary 
trunk dilatation.
A bone marrow aspiration showed 
numerous cells suggestive of Gaucher cells, 
with eccentric nuclei, abundant bluish, 
fibrillary cytoplasm resembling wrinkled 
tissue paper [Figure 2]. 
The patient was transferred to the car-
diovascular intensive care unit where she 
died 12 hours later.
Enzymatic and genetic analysis confirmed 
Gaucher disease. β-glucocerebrosidase 
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activity was 2.1 μmol/L/hr (cutoff value 
> 2.5), and two heterozygous mutations 
were detected: c.[1226A>G]; [1448T>C], 
p.[N409S]; [L483P].
Gaucher disease is a rare lysosomal 
storage disorder where mutant lysosomal 
acid β-glucocerebrosidase fails to properly 
hydrolyse its substrate, glucosylceramide, 
which accumulates in the lysosomes in cells 
of macrophage lineage. Multisystem organ 
involvement (liver, spleen, bone marrow, 
lungs, central nervous system) ensues [1,2]. 
A high degree of suspicion is required for 
Gaucher disease in the presence of spleno-
megaly or splenectomy, anemia, bone pain 
and fractures secondary to light trauma. 
Total splenectomy accelerates bone disease 
in patients with Gaucher when compared 
with partial splenectomy [3,4], and pulmo-
nary hypertension is so common after sple-
nectomy in patients with Gaucher disease 
that some experts recommend against it if 
replacement therapy is available [5]. 
In our patient the removal of the pri-
mary reservoir of storage cells through 
splenectomy likely favored the migration of 
mononuclear phagocytes toward the bones, 
liver and lungs. Our case indicates that not 
only hematologists but also orthopedists 
must keep Gaucher disease in mind so 
patients can be diagnosed early enough in 
the course of the disease. 
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Intestinal infections are a common problem for young animals. 
One explanation is the protective gut microbiota, which is not 
fully established in infants. How the microbiota might protect 
against pathogens is unclear. Kim and co-authors found that 
members of the group of strictly anaerobic, spore-forming 
bacteria known as Clostridia protect neonatal mice against 
diarrhea-causing pathogens. The protective effect is enhanced by 
giving mice the metabolite succinate in drinking water. Succinate 
favors colonization of the neonatal gut by cluster IV and XIVa 
Clostridia and concomitantly excludes Salmonella typhimurium.
Science 2017; 356: 315
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gut anaerobes protect against pathogen invasion
While amyloid and neurodegeneration are viewed together 
as Alzheimer disease pathophysiology (ADP), the factors 
that influence amyloid and AD-pattern neurodegeneration 
may be considerably different. Protection from these ADP 
factors may be important for aging without significant ADP. 
Vemuri and colleagues tried to identify the combined and 
independent protective factors for amyloid and AD-pattern 
neurodegeneration in a population-based sample and to test 
the hypothesis that “exceptional agers” with advanced ages do 
not have significant ADP because they have protective factors 
for amyloid and neurodegeneration. This cohort study included 
a prospective analysis of 942 elderly individuals (aged 70 to 
≥ 90 years) who had undergone magnetic resonance imaging 
and Pittsburgh compound B-positron emission tomography 
scans and who were enrolled in the Mayo Clinic Study of Aging, 
a longitudinal population-based study of cognitive aging 
in Olmsted County, Minnesota, USA. The authors evaluated 
predictors including demographics, Apolipoprotein E (APOE), 
intellectual enrichment, midlife risk factors (physical inactivity, 
obesity, smoking, diabetes, hypertension, and dyslipidemia), 
and the total number of late-life cardiac and metabolic 
conditions. The study participants included 423 (45%) women 
and the average age of participants was 79.7 (± 5.9) years. 
Apart from demographics and the APOE genotype, only midlife 
dyslipidemia was associated with amyloid deposition. Obesity, 
smoking, diabetes, hypertension, and cardiac and metabolic 
conditions, but not intellectual enrichment, were associated 
with greater AD-pattern neurodegeneration. In the older cohort 
(≥ 85 years), the Cohen d results showed small to moderate 
effects (effect sizes > 0.2) of several variables except job score 
and midlife hypertension in predicting exceptional aging 
without ADP.
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